Effect of a Commercially Available Carbohydrate Rich Gel on Maternal Fatigue: A Randomized Controlled Trial
NCT ID: NCT02642588
Last Updated: 2022-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-08-31
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced vs. Routine Clear Liquid Intake in Labor
NCT02524002
Effect of Oral Carbohydrate Intake > 44kCal Per Hour During Labour on the Rate of Instrumental Vaginal Delivery
NCT05080309
Oral Intake During Labor
NCT03276741
Gastric Emptying of Water and Sports Drink in Labor
NCT04229043
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
NCT07217899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
energy gel
women will be given 22 g of carbohydrates every 45-60 minutes for up to 8 hours or until delivery during the active phase of labor
energy gel
energy gel: gelatinous edible containing carbohydrates typically used during endurance races
control
women will be given only clear liquids during labor
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
energy gel
energy gel: gelatinous edible containing carbohydrates typically used during endurance races
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with BMI \< 35 kg/m\^2
* Gestational age \>37 weeks
Exclusion Criteria
* Patients unable or unwilling to provide informed consent,
* Patients who are illiterate,
* Patients who are non-English speaking or reading,
* Patients who are University Hospital employees,
* Patients undergoing induction of labor for maternal or fetal indications other than elective induction after 39 weeks or induction for post-term pregnancy
* Multi-fetal gestations (\>1 intrauterine pregnancy),
* Patients with a history of GI disorders such as hyperemesis gravidarum, inflammatory bowel disease or irritable bowel syndrome
* Patients with an increased risk of aspiration such as BMI \>35 kg/m\^2, severe GERD, gastroesophageal motility disorders,
* Patients with acute or chronic platelet dysfunction (e.g.: idiopathic thrombocytopenic purpura, HELLP syndrome) which may necessitate need for general anesthetic for Cesarean delivery
* Patients with history of peptic ulcer disease,
* Patients who have a contraindication to epidural placement and would require general anesthestetic in event of Cesarean delivery
* Patients with suspected or proven placenta accreta, increta or percreta,
* Patients with excessive nausea or vomiting during labor
* Patients with a history of food allergies or allergies to specific components found in the energy gel.
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Melissa March
UNKNOWN
Alison Bauer
UNKNOWN
Gaetan Pettigrew
UNKNOWN
Daisy Hassani
UNKNOWN
Celina Cunanan
UNKNOWN
University Hospitals Cleveland Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHCaseMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.